RNS Number : 8090D
Smith & Nephew Plc
23 February 2024

23 February 2024



Notification under Listing Rule 9.6.14



Anne-Francoise Nesmes, Chief Financial Officer of Smith & Nephew plc, will join the Board of Sanofi S.A. as an independent non-executive director with effect from 30 April 2024, subject to Sanofi shareholder approval.






Andrew Swift

Katherine Rycroft




+44 (0) 1923 477433

+44 (0) 7811 270734


Charles Reynolds




+44 (0) 1923 477314

Susan Gilchrist / Ayesha Bharmal

+44 (0) 20 7404 5959



About Smith+Nephew


Smith+Nephew is a portfolio medical technology business that exists to restore people's bodies and their self-belief by using technology to take the limits off living. We call this purpose 'Life Unlimited'. Our 19,000 employees deliver this mission every day, making a difference to patients' lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global business units of Orthopaedics, Advanced Wound Management and Sports Medicine & ENT.


Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of $5.2 billion in 2022. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms 'Group' and 'Smith+Nephew' are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.


For more information about Smith+Nephew, please visit www.smith-nephew.com and follow us on XLinkedInInstagram or Facebook.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Grafico Azioni Smith & Nephew (LSE:SN.)
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di Smith & Nephew
Grafico Azioni Smith & Nephew (LSE:SN.)
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di Smith & Nephew